Aspergillus terreus: How Inoculum Size and Host Characteristics Affect Its Virulence

Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study

(2011) M.J.G.T. Rüping et al.   JOURNAL OF HOSPITAL INFECTION

Gliotoxin as putative virulence factor and immunotherapeutic target in a cell culture model of cerebral aspergillosis

(2011) Cornelia Speth et al.   MOLECULAR IMMUNOLOGY

New species in Aspergillus section Terrei

(2011) R.A. Samson et al.   STUDIES IN MYCOLOGY

Aspergillus terreusaccessory conidia are multinucleated, hyperpolarizing structures that display differential dectin staining and can induce heightened inflammatory responses in a pulmonary model of aspergillosis

(2011) Eszter Deak et al.   Virulence

The duality ofAspergillus terreus: Differential immune responses to distinct conidia

(2011) Jatin M. Vyas   Virulence

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients

(2010) S. Perkhofer et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Aspergillus terreuscomplex

(2009) S. Arunmozhi Balajee   MEDICAL MYCOLOGY

Aspergillus terreus Accessory Conidia Are Unique in Surface Architecture, Cell Wall Composition and Germination Kinetics

(2009) Eszter Deak et al.   PLoS One

In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing

(2008) C. Lass-Florl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential Basis for Amphotericin B Resistance in Aspergillus terreus

(2008) G. Blum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Th17 cells in the setting ofAspergillusinfection and pathology

(2008) Teresa Zelante et al.   MEDICAL MYCOLOGY